Stammdaten
Unternehmen
| Name | Olema Pharmaceuticals, Inc. |
|---|---|
| Ticker | OLMA |
| CIK | 0001750284 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Olema Pharmaceuticals, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:36:19.989489 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | Mitchell Shawnte | Officer, CHIEF LEGAL OFFICER | Open Market Sale | -233 | 24.69 | -5,752.77 | -0,5% | |
| 2026-03-04 | Mitchell Shawnte | Officer, CHIEF LEGAL OFFICER | Open Market Sale | -24,767 | 24.25 | -600,599.75 | -55,4% | |
| 2026-03-03 | Mitchell Shawnte | Officer, CHIEF LEGAL OFFICER | Open Market Sale | -15,000 | 23.01 | -345,150.00 | -31,8% | |
| 2026-01-20 | Harmon Cyrus | Director | Open Market Sale | -10,000 | 26.88 | -268,800.00 | -24,8% | |
| 2026-01-15 | Kovacs Shane William Charles | Officer, CH. OPERATING & FINANCIAL OFF. | Open Market Sale | -100,000 | 28.73 | -2,873,000.00 | -265,0% | |
| 2026-01-14 | Harmon Cyrus | Director | Open Market Sale | -3,489 | 29.12 | -101,599.68 | -9,4% | |
| 2026-01-14 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -14,997 | 28.60 | -428,914.20 | -39,6% | |
| 2026-01-14 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -35,003 | 28.99 | -1,014,736.97 | -93,6% | |
| 2026-01-13 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -200 | 28.49 | -5,698.00 | -0,5% | |
| 2026-01-13 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -49,800 | 27.60 | -1,374,480.00 | -126,8% | |
| 2026-01-13 | Kovacs Shane William Charles | Officer, CH. OPERATING & FINANCIAL OFF. | Open Market Sale | -3,822 | 28.01 | -107,054.22 | -9,9% | |
| 2026-01-12 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -10,000 | 28.34 | -283,400.00 | -26,1% | |
| 2025-12-23 | Zojwalla Naseem | Officer, Chief Medical Officer | Open Market Sale | -99,509 | 27.66 | -2,752,418.94 | -253,9% | |
| 2025-12-22 | Harmon Cyrus | Director | Open Market Sale | -2,881 | 28.53 | -82,194.93 | -7,6% | |
| 2025-12-22 | Zojwalla Naseem | Officer, Chief Medical Officer | Open Market Sale | -100,000 | 28.04 | -2,804,000.00 | -258,6% | |
| 2025-12-19 | CLARK IAN T | Director | Open Market Sale | -41,840 | 30.48 | -1,275,283.20 | -117,6% | |
| 2025-12-19 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -1,225 | 28.08 | -34,398.00 | -3,2% | |
| 2025-12-19 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -43,729 | 30.40 | -1,329,361.60 | -122,6% | |
| 2025-12-19 | Myles David C. | Officer, CH. DISCOV. & NON-CLIN DEV OFF | Open Market Sale | -6,046 | 31.39 | -189,783.94 | -17,5% | |
| 2025-12-19 | Zojwalla Naseem | Officer, Chief Medical Officer | Open Market Sale | -57,079 | 28.03 | -1,599,924.37 | -147,6% | |
| 2025-12-19 | Zojwalla Naseem | Officer, Chief Medical Officer | Open Market Sale | -12,921 | 28.93 | -373,804.53 | -34,5% | |
| 2025-12-19 | CLARK IAN T | Director | Open Market Sale | -193,056 | 29.71 | -5,735,693.76 | -529,0% | |
| 2025-12-19 | CLARK IAN T | Director | Open Market Sale | -41,840 | 30.48 | -1,275,283.20 | -117,6% | |
| 2025-12-19 | CLARK IAN T | Director | Open Market Sale | -29,904 | 28.83 | -862,132.32 | -79,5% | |
| 2025-12-19 | CLARK IAN T | Director | Open Market Sale | -193,056 | 29.71 | -5,735,693.76 | -529,0% | |
| 2025-12-19 | CLARK IAN T | Director | Open Market Sale | -29,904 | 28.83 | -862,132.32 | -79,5% | |
| 2025-09-18 | Harmon Cyrus | Director | Open Market Sale | -10,000 | 8.33 | -83,300.00 | -7,7% | |
| 2025-09-18 | Harmon Cyrus | Director | Open Market Sale | -3,086 | 8.32 | -25,675.52 | -2,4% | |
| 2025-09-16 | Harmon Cyrus | Director | Open Market Sale | -1,914 | 8.08 | -15,465.12 | -1,4% | |
| 2025-09-16 | Harmon Cyrus | Director | Open Market Sale | -10,000 | 8.04 | -80,400.00 | -7,4% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.